title: Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via alpha 5 beta 1 integrin.
abstract: Integrins are considered to be an important mechanosensor in cardiac myocytes. To test whether integrins can influence cardiac contractile function, the force-frequency relationships of mouse papillary muscle bundles were measured in the presence or absence of a synthetic integrin-binding peptide, GRGDNP (gly-arg-gly-asp-asn-pro). Results demonstrate that in the presence of an arginine-glycine-aspartic acid (RGD)-containing synthetic peptide, contractile force was depressed significantly by, 28% at 4 Hz, 37.7% at 5 Hz and 20% at 10 Hz (n = 6, P < 0.01). Treatment of myofibres with either protease-generated fragments of denatured collagen (Type I) or denatured collagen that contain the RGD motif, also reduced force production significantly. An integrin-activating antibody for beta(1) integrin inhibited the force similar to synthetic RGD peptide. Function-blocking integrin antibodies for alpha(5) and beta(1) integrins reversed the effect of the RGD-containing peptide, and alpha(5) integrin also reversed the effect of proteolytic fragments of denatured collagen on contractile force, whereas experiments with function-blocking antibody for beta(3) integrin did not reverse the effect of RGD peptide. Force-[Ca(2)(+)](i) measurements showed that the depressed rate of force generation observed in the presence of the RGD-containing peptide was associated with reduced [Ca(2)(+)](i). Data analyses further demonstrated that force per unit of Ca(2)(+) was reduced, suggesting that the myofilament activation process was altered. In addition, inhibition of PKC enzyme using the selective, cell-permeable inhibitor Ro-32-0432, reversed the activity of RGD peptide on papillary muscle bundles. In conclusion, these data indicate that RGD peptide, acting via alpha(5)beta(1) integrin, depresses the force production from papillary muscle bundles, partly associated with changes in [Ca(2)(+)](i) and the myofilament activation processes, that is modulated by PKCepsilon.
authors.affiliation: Department of Medical Physiology, Cardiovascular Research Institute, 336 Reynolds Medical Building, Texas A & M University System Health Science Center, College of Medicine, College Station, TX 77843-1114, USA.
authors.forename: Vandana
authors.initials: V
authors.lastname: Sarin
authors.forename: Robert D
authors.initials: RD
authors.lastname: Gaffin
authors.forename: Gerald A
authors.initials: GA
authors.lastname: Meininger
authors.forename: Mariappan
authors.initials: M
authors.lastname: Muthuchamy
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D039081:Integrin alpha5beta1 / Q000096:biosynthesis* / Q000235:genetics; D008297:Male; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009842:Oligopeptides / Q000494:pharmacology*; D010210:Papillary Muscles / Q000187:drug effects* / Q000378:metabolism
chemical_list: D039081:Integrin alpha5beta1; D009842:Oligopeptides; C047981:arginyl-glycyl-aspartic acid
references.citation: J Physiol. 2004 Dec 15;561(Pt 3):777-91
references.pmid: 15486021
references.citation: J Natl Cancer Inst. 1956 Jun;16(6):1375-403
references.pmid: 13320119
references.citation: Cardiovasc Res. 1999 Aug 1;43(2):371-81
references.pmid: 10536667
references.citation: Exp Cell Res. 2000 Jan 10;254(1):55-63
references.pmid: 10623465
references.citation: Am J Physiol Heart Circ Physiol. 2000 Mar;278(3):H769-79
references.pmid: 10710345
references.citation: Am J Cardiol. 1999 Jun 17;83(12A):38H-43H
references.pmid: 10750585
references.citation: Am J Pathol. 2000 May;156(5):1489-98
references.pmid: 10793060
references.citation: Circ Res. 2000 Sep 15;87(6):508-15
references.pmid: 10988244
references.citation: Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H361-7
references.pmid: 11123252
references.citation: J Mol Cell Cardiol. 2001 Feb;33(2):271-82
references.pmid: 11162132
references.citation: Circ Res. 2001 Jun 8;88(11):1112-9
references.pmid: 11397776
references.citation: Cell Tissue Res. 2001 Sep;305(3):285-98
references.pmid: 11572082
references.citation: Circ Res. 2002 Mar 8;90(4):458-64
references.pmid: 11884376
references.citation: Circ Res. 2002 Mar 8;90(4):473-80
references.pmid: 11884378
references.citation: Trends Cardiovasc Med. 2002 Apr;12(3):97-101
references.pmid: 12007733
references.citation: Am J Physiol Heart Circ Physiol. 2003 Jan;284(1):H122-32
references.pmid: 12485818
references.citation: Circulation. 2003 Feb 25;107(7):1046-52
references.pmid: 12600920
references.citation: Cardiovasc Res. 2003 Mar;57(3):766-74
references.pmid: 12618238
references.citation: J Biol Chem. 2003 Mar 28;278(13):11265-72
references.pmid: 12551921
references.citation: J Vasc Res. 2003 May-Jun;40(3):211-33
references.pmid: 12902635
references.citation: J Biol Chem. 2003 Oct 24;278(43):42214-24
references.pmid: 12909616
references.citation: Am J Physiol Cell Physiol. 2004 Mar;286(3):C518-28
references.pmid: 14761883
references.citation: Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H889-94
references.pmid: 14576082
references.citation: J Biol Chem. 1985 Mar 25;260(6):3440-50
references.pmid: 3838314
references.citation: Biochem Biophys Res Commun. 1992 Feb 14;182(3):1025-31
references.pmid: 1540151
references.citation: Cell Motil Cytoskeleton. 1992;21(2):87-100
references.pmid: 1373110
references.citation: Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9051-5
references.pmid: 7692444
references.citation: Biophys J. 1993 Aug;65(2):693-701
references.pmid: 8218897
references.citation: Biophys J. 1994 Jul;67(1):273-82
references.pmid: 7918995
references.citation: Cardiovasc Drugs Ther. 1995 Aug;9(4):581-7
references.pmid: 8547208
references.citation: Biochemistry. 2004 May 25;43(20):5996-6004
references.pmid: 15147183
references.citation: Mol Biol Cell. 2004 Jun;15(6):2558-67
references.pmid: 15034138
references.citation: Cardiovasc Res. 2004 Aug 15;63(3):381-90
references.pmid: 15276463
references.citation: J Physiol. 2004 Aug 1;558(Pt 3):927-41
references.pmid: 15194741
references.citation: Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
references.pmid: 388439
references.citation: Circ Res. 1996 Oct;79(4):821-6
references.pmid: 8831506
references.citation: Biophys J. 1996 Oct;71(4):1891-904
references.pmid: 8889164
references.citation: J Mol Biol. 1997 Feb 14;266(1):8-14
references.pmid: 9054965
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 2):H175-82
references.pmid: 9249488
references.citation: J Clin Invest. 1997 Sep 15;100(6):1647-53
references.pmid: 9294134
references.citation: J Biol Chem. 1998 Mar 20;273(12):6670-8
references.pmid: 9506964
references.citation: J Cell Sci. 1998 Apr;111 ( Pt 8):1117-26
references.pmid: 9512507
references.citation: Circ Res. 1998 Sep 7;83(5):471-80
references.pmid: 9734469
references.citation: J Cell Biol. 1998 Oct 5;143(1):241-52
references.pmid: 9763435
references.citation: Circ Res. 1999 Jan 8-22;84(1):122-4
references.pmid: 9915781
references.citation: Am J Physiol. 1999 Feb;276(2 Pt 2):H642-50
references.pmid: 9950866
references.citation: Lab Invest. 1958 Mar-Apr;7(2):134-7
references.pmid: 13540204
references.citation: J Biol Chem. 1996 Oct 11;271(41):25099-106
references.pmid: 8810264